Long-acting Bio-betters
Total Trials
4
As Lead Sponsor
As Collaborator
0
Total Enrollment
450
NCT03242239
A Comparing Study Between ALT02(Trastuzumab Biosimilar) and Herceptin® in Healthy Subjects
Phase: Phase 1
Role: Lead Sponsor
Start: Feb 9, 2016
Completion: Sep 30, 2016
NCT03281824
Clinical Study of ALT-P7 to Determine Safety, Tolerability and Pharmacokinetics in Breast Cancer Patients
Start: Jan 11, 2018
Completion: Jan 15, 2021
NCT04058535
Clinical Study of ALT-L9 to Determine Safety, Efficacy and Pharmacokinetics in Neovascular AMD
Start: Feb 5, 2020
Completion: Dec 22, 2020
NCT05232175
Clinical Study of ALT-BB4 to Determine Tolerance, Safety and Pharmacokinetics in Healthy Volunteer
Start: Jan 18, 2022
Completion: Aug 24, 2022
Loading map...